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ABSTRACT
Background: Guidelines on the required number of ambulatory blood pressure (ABP) readings
focus on individual patients. Clinical researchers often face the dilemma of applying recommen-
dations and discarding potentially valuable information or accepting fewer readings.
Methods: Starting from ABP recordings with30/10 awake/asleep readings in 4277 partici-
pants enrolled in eight population studies in the International Database on Ambulatory Blood
Pressure in Relation to Cardiovascular Outcomes (IDACO), we randomly selected a certain
number of readings (from 30 to 1 awake and 10 to 1 asleep readings) at a time over 1000
bootstraps at each step. We evaluated: (i) concordance of the ABP level; (ii) consistency of the
cross-classification based on office blood pressure and ABP; and (iii) accuracy in predicting
cardiovascular complications. For each criterion, we fitted a regression line joining data points
relating outcome to the number of readings covering the ranges of 30-20/10-7 for awake/
asleep readings.
Results: Reducing readings widened the SD of the systolic/diastolic differences between full
(reference) and selected recordings from 1.7/1.2 (30 readings) to 14.3/10.3mm Hg (single
reading) during wakefulness, and from 1.9/1.4 to 10.3/7.7mm Hg during sleep; lowered the
j statistic from 0.94 to 0.63, and decreased the hazard ratio associated with 10/5mm Hg
increments in systolic/diastolic ABP from 1.21/1.14 to 1.06/1.04 during wakefulness and from
1.26/1.17 to 1.14/1.08 during sleep. The first data points falling off these regression lines during
wakefulness/sleep corresponded to 8/3 and 8/4 readings for criteria (i) and (iii) and to 5 awake
readings for criterion (ii).
Conclusions: 24-h ambulatory recordings with8/4 awake/asleep readings yielded ABP levels
similar to recordings including the guideline-recommended20/7 readings. These criteria save
valuable data in a research setting, but are not applicable to clinical practice.
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Introduction
The Global Burden of Diseases Study 2010 reported
that high blood pressure is the leading risk factor for
ill health and causes 9.4 million deaths every year —
more than half of the estimated 17 million deaths per
year attributable to total cardiovascular disease [1,2].
North American [3,4], European [5,6] Japanese [7]
and Chinese [8] guidelines unanimously recommend
ambulatory blood pressure monitoring as the state-of-
the-art technology to be used. Wearing an ambulatory
blood pressure monitor causes discomfort that
increases with the number of cuff inflations during
normal daily activities and sleep. Current recommen-
dations on the number of ambulatory readings
required for estimating the 24-h, awake or asleep
blood pressure levels are focusing on the management of
hypertension in individual patients. Recommendations
vary from obtaining at least 70% of the programmed
readings without providing a specific number [6,9]
to 20 awake or daytime and 7 asleep or nighttime
readings [6].
For analysis of the International Database on
Ambulatory Blood Pressure in Relation to
Cardiovascular Outcomes (IDACO) [10–12], we con-
sistently applied short fixed clock time interval
excluding the transition periods in the morning and
evening, when in most people blood pressure level
rapidly changes upon awaking or going to sleep, and
we set the standard to 10 daytime and 5 nighttime
readings [10–12]. We re-analyzed the IDACO
database with as objective to determine how many
readings are required to capture the awake and asleep
blood pressure in epidemiological studies. While using
full recordings as the reference, we applied three
criteria: (i) concordance of the blood pressure level
between full and randomly reduced recordings; (ii)
consistency of the cross-classification based on office
and the awake blood pressure; and (iii) maintenance
of the accuracy in predicting cardiovascular complications.
Methods
Study population
Previous publications have described the IDACO
database in detail [10–12]. Population studies qualified
for inclusion if information on the office and the
ambulatory blood pressure and cardiovascular risk
factors was available at baseline and if follow-up
included both fatal and nonfatal outcomes. All studies
received ethical approval and adhered to the princi-
ples of the Declaration of Helsinki [13]. Participants
gave written informed consent. Of the 13,111 people
included in the database, we selected 4277 [14–20]
based on the following criteria: (i) availability of a
diary; and (ii) at least 30 readings during wakefulness
and 10 readings during sleep.
Blood pressure measurement
The office blood pressure was the average of two
readings. We programmed blood pressure monitors to
obtain ambulatory readings at 30-minute intervals
throughout the whole day [18], or at intervals ranging
from 15 [16,17,20] to 20 [14,15,19] minutes during
wakefulness and at intervals of 30 [16,17,20], 40
[14,15] or 45 [19] minutes during sleep. The same
SAS macro processed all ambulatory recordings,
which remained unedited or were sparsely edited [18].
For the main analysis, we determined the awake and
asleep periods from the participants’ diary cards. We
applied guideline-endorsed criteria [3–8] to define
office and ambulatory hypertension and to categorize
individuals based on office and awake ambulatory
blood pressure into normotensive people and patients
with white-coat, masked and sustained hypertension,
irrespective of antihypertensive drug treatment [21]. If
systolic and diastolic blood pressure fell in different
categories, participants were assigned to the highest
category. In sensitivity analyses, we defined daytime
as the interval from 10 AM to 8 PM in Europeans
[14,16,17,20] and South Americans [15] and from
8 AM to 6 PM in Asians [18,19]. The corresponding
nighttime intervals ranged from midnight to 6 AM
[14–17,20] and from 10 PM to 4 AM [18,19], respect-
ively. These fixed intervals eliminate the transition
periods in the morning and evening when blood pres-
sure changes rapidly, resulting in daytime and night-
time blood pressure levels that are within 1–2mm Hg
of the awake and asleep levels [22].
Ascertainment of events
We ascertained vital status and the incidence of fatal
and nonfatal illnesses from the appropriate sources in
each country. Outcomes were coded according to
the international classification of diseases (ICD). The
cardiovascular endpoint included cardiovascular
mortality, sudden death, heart failure and other
nonfatal cardiac, coronary and cerebrovascular
complications, not including transient ischemic attack.
Statistical analysis
For database management and statistical analysis, we
used SAS software version 9.4 (SAS Institute
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Inc., Cary, NC). Significance was a two-tailed a-level
of 0.05 or less. Means and proportions were compared
using a large sample z-test and Fisher’s exact test,
respectively.
Starting from full recordings, we applied the PROC
SURVEYSELECT procedure as implemented in the
SAS package to select in a random manner awake and
asleep readings without replacement. While using full
recordings as the reference, we determined the min-
imum number of awake and asleep readings required
to satisfy three criteria: (i) concordance of the blood
pressure level between full and reduced recordings;
(ii) consistency of the cross-classification based on
office and the ambulatory blood pressure; and (iii)
maintenance of the accuracy in predicting cardiovas-
cular complications. We bootstrapped all analyses at
each step of data reduction to obtain the mean of
1000 point estimates for each criterion. We assessed
the concordance of the blood pressure level between
full and reduced recordings from the SD of the mean
differences between full and randomly reduced
recordings. We applied the j statistic for the assess-
ment of the consistency of the classification of the
awake and asleep blood pressure into normotension
and ambulatory hypertension. Hypertension during
wakefulness was a blood pressure of at least 135mm
Hg systolic or 85mm Hg diastolic. 24-h ambulatory
hypertension was a blood pressure of at least 130mm
Hg systolic or 80mm Hg diastolic. The consistency of
the prognostic value of the awake and asleep blood
pressure was assessed from Cox models stratified for
cohort and adjusted for sex, age, body mass
index, office blood pressure, the total-to-high-density-
lipoprotein cholesterol ratio, smoking and drinking,
history of cardiovascular disease and diabetes mellitus,
and antihypertensive treatment. We linearized the
associations of the averages of the SDs (criterion i),
j statistics (criterion ii) or hazard ratios (criterion iii)
with the number of readings retained in the record-
ings by a logarithmic transformation. After lineariza-
tion of the association between the outcome criteria
(SD, j or hazard ratio) and the number of readings
retained in the analysis, we drew a regression line
through the data points derived from recordings with
30 awake and 10 asleep readings up to recordings
including 20 awake and 7 asleep readings as recom-
mended by the guidelines [6,9]. The first data point
that fell off this regression line was used to determine
the minimum required number of readings. By using
this approach, we accounted for current guidelines
[6,9]. We also estimated the number of readings
required to estimate the ambulatory blood pressure
level in individual subjects with a 5% precision com-
pared with full recordings. A 5% precision was an
absolute difference in the blood pressure level between
reduced and full recordings within the 2.5 to 97.5th
percentile interval of the signed differences.
Results
Baseline characteristics of participants
Of 4277 participants, 2233 (52.2%) were women, 3349
(78.3%) were White and 326 (7.6%) and 602 (14.1%)
were Chinese and Japanese, respectively. Current
smoking was reported by 1418 (33.2%) participants
and drinking alcohol by 2530 (59.2%). The prevalence
of diabetes was 237 (5.5%) and 324 participants
(7.6%) had a history of cardiovascular disease.
Age averaged 50.9 ± 14.7 years (5th–95th percentile
interval, 24.1–71.9 years). Table 1 lists the baseline
characteristics categorized by the incidence of cardio-
vascular events during follow-up. With the exception
of drinking alcohol, cardiovascular risk factors had a
higher prevalence or higher level in cases with
incident cardiovascular complications compared with
non-cases.
In all participants office systolic/diastolic blood
pressure averaged 129.3/80.0mm Hg. The median
(5th to 95th percentile interval) number of ambula-
tory readings averaged to estimate the 24-h, awake,
daytime, asleep and nighttime blood pressures were
73 (47–82), 56 (32–70), 37 (20–42), 15 (11–22) and 12
(8–13), respectively. Mean values of the 24-h, awake
Table 1. Baseline characteristics of participants by incident
cardiovascular disease.
Characteristic Non-Cases Cases All
Number (%) of participants 3660 617 4277
Women 1984 (54.2) 249 (40.4) 2233 (52.2)
Current smoking 1177 (32.2) 241 (39.1) 1418 (33.2)
Drinking alcohol 2164 (59.1) 366 (59.3) 2530 (59.2)
Diabetes 171 (4.7) 66 (10.7) 237 (5.5)
Previous cardiovascular diseases 200 (5.5) 124 (20.1) 324 (7.6)
White ethnicity 2866 (78.4) 481 (78.0) 3349 (78.3)
Mean (±SD) characteristic
Age, years 48.9 ± 14.4 63.2 ± 10.2 50.9 ± 14.7
Body mass index, kg/m2 25.1 ± 4.2 26.0 ± 4.3 25.2 ± 4.3
Total serum cholesterol, mmol/L 5.52 ± 1.21 5.99 ± 1.19 5.59 ± 1.22
HDL cholesterol, mmol/L 1.39 ± 0.39 1.30 ± 0.39 1.37 ± 0.39
Total-to-HDL cholesterol ratio 4.32 ± 2.81 5.00 ± 2.12 4.42 ± 2.73
Blood pressure, mm Hg
Office systolic 127.5 ± 18.3 140.0 ± 20.3 129.3 ± 19.1
Office diastolic 79.5 ± 11.2 83.0 ± 12.2 80.0 ± 11.5
24-h systolic 122.4 ± 12.6 130.9 ± 14.5 123.7 ± 13.2
24-h diastolic 73.3 ± 8.3 76.2 ± 8.9 73.7 ± 8.4
Awake systolic 128.1 ± 13.1 136.2 ± 15.0 129.3 ± 13.7
Awake diastolic 77.9 ± 8.6 80.3 ± 9.3 78.3 ± 8.7
Asleep systolic 110.5 ± 12.9 119.6 ± 15.7 111.8 ± 13.7
Asleep diastolic 63.8 ± 8.8 67.5 ± 9.5 64.3 ± 9.0
HDL indicates high-density lipoprotein. Differences between non-cases
and cases were all significant (p< .0001) except for ethnicity and drinking
alcohol (p .83).
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and asleep blood pressures in all participants were
123.7/73.7mm Hg, 129.3/78.3mm Hg and 111.8/
64.3mm Hg, respectively. The average daytime and
nighttime blood pressures were all within 1.2mm Hg
systolic and 0.8mm Hg diastolic of the corresponding
diary-based awake and asleep levels.
Criterion I: consistency of the ambulatory blood
pressure level
Compared with full recordings, randomly reducing
the number of readings to a single measurement over
1000 bootstraps did not yield mean differences in the
blood pressure level at any bootstrap loop greater
than 0.69mm Hg systolic or 0.47mm Hg diastolic
during wakefulness or sleep (Figure 1), but widened
the SD of the mean differences on average from
1.7 to 14.3mm Hg systolic and from 1.2 to 10.3mm
Hg diastolic during wakefulness, and from 1.9 to
10.3mm Hg systolic and from 1.4 to 7.7mm Hg
diastolic during sleep (Figure 2). Next, we linearized
the vertical axes by a logarithmic transformation and
fitted regression lines joining the data points from
recordings with 30 awake and 10 asleep readings up
to recordings including 20 awake and 7 asleep
readings as recommended by the guidelines. For the
awake and asleep blood pressures, the last data point
still on the regression line was derived from record-
ings including 8 and 3 readings during wakefulness
and sleep, respectively (Figure 2). Using a similar
strategy, the number of daytime and nighttime read-
ings was 6 and 3, respectively. In addition, based on
individual blood pressure difference between reduced
and full recordings, Table 2 provides the number of
readings required to estimate blood pressure in indi-
vidual subjects with a 5% precision.
Criterion II: consistency of categorization
Of 4277 participants, 2371 (55.4%) were normotensive
on office and awake ambulatory measurement,
while 412 (9.6%), 538 (12.6%) and 956 (22.4%) had
white-coat, masked or sustained hypertension. Using
the 24-h ambulatory blood pressure instead of the
blood pressure during wakefulness yielded similar
numbers: 2430 (56.8%) for normotension and 444
(10.4%) 479 (11.2%) and 924 (21.6%) for white-coat,
masked and sustained hypertension, respectively.
Figure 3 shows the concordance in the discrimination
between normotension and hypertension during
wakefulness. The j statistic was plotted over 1000
bootstraps randomly reduced recordings during
30 25 20 15 10 5 1
S
B
P
 D
iff
er
en
ce
, m
m
 H
g
0.6
0.4
0
−0.4
−0.6
0.2
−0.2
D
B
P
 D
iff
er
en
ce
, m
m
 H
g
0.4
0
−0.4
0.2
−0.2
0.4
0
−0.4
0.2
−0.2
10 9 8 7 6 5 4 3 2 1
30 25 20 15 10 5 1
0.4
0
−0.4
0.2
−0.2
10 9 8 7 6 5 4 3 2 1
(A) (B)
(C) (D)
N° of Awake Readings N° of Asleep Readings
Difference and 95% CI 
Difference and 95% CI 
Figure 1. Differences between awake (A,C) and asleep (B,D) systolic (SBP) and diastolic (DBP) blood pressure levels derived from
full recordings and randomly reduced recordings. Estimates at each step are means over 1000 bootstrap loops. Vertical bars
denote the 95% confidence interval.
344 W-Y. YANG ET AL.
wakefulness. After linearizing the horizontal axis by a
logarithmic transformation, regression lines were fit-
ted joining the data points from recordings including
30 to 20 awake readings. The last data point still on
the regression line was for 5 readings. Using a similar
strategy, the number of daytime readings required to
correctly differentiate normotension from hyperten-
sion in daytime ambulatory readings was 3.
Criterion III: consistency of prediction of
cardiovascular outcome
Over a median follow-up of 14.4 years (5th–95th
percentile interval, 2.4–24.4 years), 617 participants
experienced a cardiovascular complication. The multi-
variable-adjusted hazard ratios associated with a
10/5mm Hg higher systolic/diastolic blood pressure
derived from full recordings were 1.21 (CI, 1.13 to 1.31)
systolic and 1.14 (CI, 1.08 to 1.21) diastolic during
wakefulness; the corresponding estimates were 1.28 (CI,
1.20 to 1.35) and 1.18 (CI, 1.12 to 1.24) for the period
during sleep (p< .0001 for all). In fully reduced record-
ings with single reading, the mean hazard ratios of 1000
bootstraps decreased to 1.06 (CI, 1.02 to 1.11) systolic
and 1.04 (CI, 1.01 to 1.07) diastolic during wakefulness
and to 1.14 (CI, 1.09 to 1.19) systolic and 1.08 (CI, 1.04
to 1.12) diastolic during sleep.
Figure 4 depicts the multivariable-adjusted hazard
ratios for a fatal or nonfatal cardiovascular event
associated with the awake and asleep blood pressures,
as derived at each step of data selection over 1000
bootstraps. After linearizing the horizontal axis by a
logarithmic transformation, regression lines were
fitted joining the data points from the recordings with
30 and 10 readings and from recordings including 20
and 7 readings during wakefulness and sleep, respect-
ively. The last data points still on the regression line
were derived from 8 readings during wakefulness and
4 during sleep. The number of daytime and nighttime
readings required to predict a cardiovascular compli-
cation was 6 and 3, respectively.
Discussion
Current guidelines [3–8] unanimously recommend
ambulatory blood pressure monitoring as the state-of-
the-art technology to be used to diagnose and manage
hypertension. Current recommendations on the num-
ber of required readings focus on the management of
hypertension in individual patients and vary from
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obtaining at least 70% of the programmed readings
without providing a specific number [6,9] to 20 awake
or daytime and 7 asleep or nighttime readings [6].
However, in epidemiological or clinical studies,
researchers often face the dilemma of applying these
recommendations, thereby discarding potentially valu-
able information or accepting fewer readings to keep
more recordings in the analyses. In reports of the
IDACO database [10–12] or the Jackson Heart Study
[23,24], the standard was set to 10 daytime and 5
nighttime readings. The novelty of the present
analyses is that we demonstrated that in epidemio-
logical studies 8 awake and 4 asleep or 6 daytime and
3 nighttime readings were sufficient to estimate the
ambulatory blood pressure level, diagnose ambulatory
hypertension and assess the relative risk of a cardio-
vascular complication.
Obviously, the higher the number of ambulatory
readings obtained, the more representative a recording
is for an individual’s blood pressure level. However,
cuff inflations during intermittent ambulatory blood
pressure monitoring causes muscle compression, pain
or discomfort at the arm [25–27], disturbs sleep
[6,28–30], and therefore potentially affects the accur-
acy of blood pressure assessment [29,30], especially in
hypertensive patients [27] or patients with sleeping
disorders [29]. Cuff inflations can be extremely
annoying in shift workers during the transition peri-
ods from daytime to nighttime work or in assembly-
line workers, who have to keep up with an imposed
production rhythm. In a recent study of 336 shift
laborers doing chain work, we had to exclude 80
(23.8%) participants, because they declined ambula-
tory blood pressure monitoring (n¼ 24) or because
they had fewer than 7 or 3 readings during wakeful-
ness or sleep (n¼ 56) [31]. The discomfort caused by
too frequent cuff inflation can also result in resistance
from patients to having repeat ambulatory blood pres-
sure monitoring [6]. These considerations explain why
in clinical and epidemiological research, investigators
have to strike a compromise between what might be
ideal and what is acceptable to study participants.
Based on our present findings, we do not suggest
reducing the ambulatory blood pressure readings to
Table 2. Number of readings required for a 5% precision of
the blood pressure differences in individual subjects.
Systolic/diastolic blood pressure thresholds
N of readings Awake Asleep Daytime Nighttime
1 28.9 / 20.4 20.4 / 15.3 28.7 / 19.9 20.3 / 15.3
2 20.1 / 14.3 14.0 / 10.5 19.9 / 13.9 13.7 / 10.4
3 16.3 / 11.5 11.0 / 8.2 16.1 / 11.2 10.6 / 8.0
4 14.0 / 9.9 9.1 / 6.8 13.7 / 9.5 8.6 / 6.5
5 12.4 / 8.8 7.8 / 5.8 12.1 / 8.4 7.2 / 5.4
6 11.2 / 7.9 6.7 / 5.0 10.9 / 7.5 6.1 / 4.5
7 10.3 / 7.2 5.8 / 4.4 9.9 / 6.8 5.1 / 3.8
8 9.5 / 6.7 5.1 / 3.8 9.1 / 6.3
9 8.9 / 6.2 4.4 / 3.4 8.4 / 5.8
10 8.3 / 5.8 3.9 / 2.9 7.8 / 5.4
11 7.8 / 5.5 7.3 / 5.0
12 7.4 / 5.2 6.8 / 4.7
13 7.0 / 4.9 6.4 / 4.4
14 6.7 / 4.7 6.0 / 4.1
15 6.4 / 4.5 5.7 / 3.9
16 6.1 / 4.3 5.4 / 3.7
17 5.8 / 4.1 5.1 / 3.5
18 5.6 / 3.9 4.8 / 3.3
19 5.4 / 3.8 4.5 / 3.1
20 5.1 / 3.6 4.3 / 2.9
21 4.9 / 3.5
22 4.8 / 3.3
23 4.6 / 3.2
24 4.4 / 3.1
25 4.3 / 3.0
26 4.1 / 2.9
27 4.0 / 2.8
28 3.8 / 2.7
29 3.7 / 2.6
30 3.6 / 2.5
A 5% precision indicates an absolute difference in the blood pressure
level between reduced and full recordings within 2.5 to 97.5th percentile
interval of the signed differences.
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less than what is common practice today in most
studies. However, our observations suggest that in
studies, in which the blood pressure level is the
primary variable of interest, one might relax the
guideline-endorsed criteria about the number of
readings required to keep a maximum of study partic-
ipants in the analysis.
More than 30 years ago, Di Rienzo and colleagues
[32] addressed a similar research question in 40 hos-
pitalized patients who underwent continuous intra-
arterial blood pressure monitoring, using the Oxford
method [33]. The intra-arterial blood pressure signal
was analyzed by a computer to obtain the 24-h
average blood pressure. The overall 24-h average was
then compared with the average beat-to-beat blood
pressure obtained by beat-to-beat analysis of periods
ranging in duration from 30minutes up to 12 hours.
Differences between the 24-h and sub-period means
remained prominent up to 4-h periods and only atte-
nuated when blood pressure was averaged over 8 to
12 hours [32].
Our current findings combined with other studies
highlighting the discomfort caused by cuff inflation
raise the question whether cuffless blood pressure
measurement might be an alternative to the oscillo-
metric approach. Measurement of pulse transmit time
is one approach to cuffless blood pressure monitoring.
Pulse transit time is the interval between the peak of
electrocardiographic R-wave and the arrival of the
pulse wave in the fingertip or wrist as assessed by
photoplethysmography [34]. However, cuffless meas-
urements differed as much as -19.3 to 18.2mm Hg
from simultaneous oscillometric readings and the
proportion of people with systolic blood pressure
differences between the two methods exceeding 5mm
Hg was 45.9% and 65.7% in the supine and standing
position, respectively [34]. For a smartphone-based
application, the proportion of systolic readings deviat-
ing more than 5mm Hg was 76.0% [35]. None of
these devices would have passed current validation
criteria for blood-pressure measuring devices [36].
Computation of blood pressure variability obvi-
ously requires more ambulatory readings than is
required for the determination of blood pressure level.
A previous IDACO publication had as objective to
determine the minimum number of readings needed
to compute average real variability (AVR) without
loss of prognostic information [37]. ARV was first
calculated from a discovery dataset that included 24-h
ambulatory blood pressure measurements from 1254
residents (43.5% women; mean age, 56.6 years) of
Copenhagen, Denmark. Concordance between ARV
from full (80 or more blood pressure readings) and
randomly reduced 24-h blood pressure recordings was
examined, as was prognostic accuracy. A test dataset
that included 5353 individuals (45.6% women; mean
age, 54.0 years) with at least 48 blood pressure meas-
urements from 11 randomly recruited population
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Figure 4. Multivariable-adjusted hazard ratios for a fatal or nonfatal cardiovascular complication associated with a 10-mm Hg
higher systolic blood pressure (A,D [SBP]) or a 5-mm Hg higher diastolic blood pressure (B,E [DBP]) as derived from over
1000 bootstraps randomly reduced recordings during wakefulness (A,B) and sleep (D,E). Vertical bars denote the 95% confidence
interval. After linearizing the horizontal axis by a logarithmic transformation, regression lines were fitted joining the data points
from recordings including 30 to 20 readings during wakefulness (C) and from 10 to 7 readings during sleep (F). The last data
points still on the regression line were derived from 8 readings during wakefulness and 4 during sleep.
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cohorts was used to validate the results. In the test
dataset, over 10.2 years (median), 806 participants
died (335 cardiovascular including 206 cardiac deaths)
and 696 experienced a major fatal or nonfatal cardio-
vascular event. Forty-eight blood pressure readings
over 24 hours were adequate to compute ARV without
meaningful loss of prognostic information [37].
The current study should be interpreted within the
context of its limitations. First, our findings should
not be used to reduce the number of programmed
ambulatory blood pressure readings or lengthen the
interval between ambulatory readings in managing
individual patients in clinical practice. Clinicians
should follow current guidelines [6,9] and obtain the
maximum number of readings achievable within their
health care setting and acceptable to their patients.
However, Table 2 provides information of the number
of ambulatory readings to estimate the blood pressure
level with 5% precision in individual patients. It
allows clinicians to determine the number of readings
required for clinical research and patient management
or choose for the same precision in both settings.
Second, the number of required readings in our cur-
rent analyses should not be extrapolated to studies
with a focus on blood pressure variability or on the
diurnal rhythmicity of blood pressure. However, com-
pared with blood pressure level, blood pressure vari-
ability is a substantially weaker predictor of
cardiovascular risk [37–39]. Third, for sake of general-
izability, we reported the minimum number of
daytime and night-time readings for investigators
applying short fixed time intervals excluding the tran-
sition periods in the morning and evening when
blood pressure usually changes rapidly [22]. However,
the diary method to document wakefulness and sleep
remains the approach to be favored [3–8]. Fourth, we
simulated incomplete ambulatory blood pressure
recordings by randomly removing readings from the
full recordings. This procedure implicitly assumes that
failed readings are missing at random. This assump-
tion might not be true because measurement failure
might occur more frequently during certain parts of
the day as a consequence of noise due to physical
activity or other stressors [40]. In addition, incomplete
recordings might occur as a result of a subject taking
off the recorder because of discomfort. However, the
concern that readings might be missing not randomly
would particularly apply to full 24 h ambulatory
recordings, but to a lesser extent to separate analyses
of the awake and asleep blood pressures or the day-
and night-time blood pressures. Finally, we did not
plot our results over a full 24-h recording period,
because the variable number of recordings during
wakefulness and sleep added too much complexity to
the computations. However, compared with hyperten-
sion cross-classification by using 24-h ambulatory
blood pressure derived from full readings, the j statis-
tic of randomly reduced recording were as high as
0.87 (CI, 0.86 to 0.88) if 8 awake and 4 asleep read-
ings retained in current study.
In conclusion, in an epidemiological context, as
few as 8 awake and 4 asleep or 6 daytime and 3 night-
time readings are sufficient to estimate the ambulatory
blood pressure level without meaningful loss of
information in hypertension categorization or risk
stratification. Experts might translate our observations
into recommendations on the number of ambulatory
readings to be included in analyses of clinical studies.
To minimize discomfort for patients, guidelines
should not only address the minimum number of
readings to be obtained in patients during wakefulness
and sleep, but also propose a threshold for the
maximum number of readings that patients can
tolerate without discomfort.
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